Chen Lina, Xiao Guosu, Yu Zhou, Huang Niwen, Cheng Yiju
Department of Respiratory and Critical Care Medicine, The Affiliated Hospital of Guizhou Medical University, Guiyang, 550001, Guizhou, China.
Department of Clinical Medicine, Guizhou Medical University, Guiyang, 550001, Guizhou, China.
Iran J Basic Med Sci. 2024;27(11):1423-1429. doi: 10.22038/ijbms.2024.79246.17166.
This investigation explored the mechanism by which the total flavonoids of (P.Beauv.) Spring (TFST) mitigate oxidative stress through the activation of the heme oxygenase-1 (HO-1) signaling pathway mediated by nuclear factor erythroid 2-related factor 2 (Nrf2), thereby ameliorating acute lung injury (ALI) induced by diabetes.
Male mice weighing 20-25 grams were divided into four groups: a control group, a diabetic group, a diabetic group treated with TFST, and a diabetic group treated with TFST and ML385. Various biological specimens were collected for analysis, including bronchoalveolar lavage fluid (BALF), blood, and tissue samples. These were subjected to a range of assessments covering hematological and BALF parameters tumor necrosis factor-alpha (TNF-α), interleukin-6 [IL-6]), biochemical markers (malondialdehyde [MDA], superoxide dismutase [SOD], glutathione peroxidase [GSH], Nrf2, and HO-1 levels), along with histopathological evaluations.
Pre-treatment with TFST demonstrated a significant decrease in pulmonary tissue damage, evidenced by decreased wet-to-dry (W/D) lung ratios (<0.001), reduced lung injury scores (<0.0001), and lower levels of TNF-α, IL-6 (<0.0001), as well as oxidative stress markers like MDA (<0.05). Moreover, there was an elevation in the activity of anti-oxidative enzymes, specifically SOD and GSH (<0.05), coupled with an enhanced expression of Nrf2 and HO-1 in the diabetic group (<0.01).
The study findings demonstrate that TFST can suppress oxidative stress by modulating the Nrf2 pathway and up-regulating HO-1 activity, thereby ameliorating diabetes-induced acute lung injury.
本研究探讨了矮牵牛(P.Beauv.)斯普林(TFST)总黄酮通过激活由核因子红细胞2相关因子2(Nrf2)介导的血红素加氧酶-1(HO-1)信号通路减轻氧化应激的机制,从而改善糖尿病诱导的急性肺损伤(ALI)。
将体重20-25克的雄性小鼠分为四组:对照组、糖尿病组、TFST治疗的糖尿病组和TFST与ML385联合治疗的糖尿病组。收集各种生物标本进行分析,包括支气管肺泡灌洗液(BALF)、血液和组织样本。对这些标本进行一系列评估,涵盖血液学和BALF参数、肿瘤坏死因子-α(TNF-α)、白细胞介素-6[IL-6])、生化标志物(丙二醛[MDA]、超氧化物歧化酶[SOD]、谷胱甘肽过氧化物酶[GSH]、Nrf2和HO-1水平),以及组织病理学评估。
TFST预处理显示肺组织损伤显著减轻,表现为肺湿干比(W/D)降低(<0.001)、肺损伤评分降低(<0.0001)、TNF-α、IL-6水平降低(<0.0001),以及MDA等氧化应激标志物水平降低(<0.05)。此外,抗氧化酶(特别是SOD和GSH)的活性升高(<0.05),同时糖尿病组中Nrf2和HO-1的表达增强(<0.01)。
研究结果表明,TFST可通过调节Nrf2途径和上调HO-1活性来抑制氧化应激,从而改善糖尿病诱导的急性肺损伤。